financetom
Business
financetom
/
Business
/
Cirrus Logic Fiscal Q1 Non-GAAP EPS, Sales Rise; Q2 Guidance Issued -- Shares Up After Hours
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cirrus Logic Fiscal Q1 Non-GAAP EPS, Sales Rise; Q2 Guidance Issued -- Shares Up After Hours
Aug 6, 2024 1:44 PM

04:25 PM EDT, 08/06/2024 (MT Newswires) -- Cirrus Logic ( CRUS ) reported fiscal Q1 non-GAAP earnings late Tuesday of $1.12 per diluted share, up from $0.67 a year earlier.

Analysts polled by Capital IQ expected $0.62.

Net sales for the quarter ended June 29 were $374 million, compared with $317 million a year earlier. Analysts polled by Capital IQ expected $318.4 million.

The company said it expects fiscal Q2 revenue of $490 million to $550 million. Analysts expect $485.3 million.

Company shares were up nearly 12% in recent after-hours activity.

Price: 129.00, Change: +13.69, Percent Change: +11.87

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Instant View: Nvidia's $5 billion bet on Intel
Instant View: Nvidia's $5 billion bet on Intel
Sep 18, 2025
(Reuters) -Nvidia said on Thursday it will invest $5 billion in Intel, throwing its heft behind the struggling U.S. chip foundry weeks after the White House engineered a deal for the U.S. government to take a massive stake in the company. Nvidia's support represents a new opening for Intel after years of turnaround efforts at the famed U.S. manufacturer failed...
GoldHaven Resources Arranges Non-Brokered Private Placement
GoldHaven Resources Arranges Non-Brokered Private Placement
Sep 18, 2025
07:52 AM EDT, 09/18/2025 (MT Newswires) -- GoldHaven Resources ( GHVNF ) overnight Wednesday said it plans to conduct a non-brokered private placement for gross proceeds of up to C$175,000. The offering will include up to around 1.3 million shares at $0.13 each. The company will use the gross proceeds from the offering for general working capital and business development....
BRIEF-Biogen To Buy Alcyone Therapeutics, Expanding Drug Delivery Solutions For Key Products and Pipeline
BRIEF-Biogen To Buy Alcyone Therapeutics, Expanding Drug Delivery Solutions For Key Products and Pipeline
Sep 18, 2025
Sept 18 (Reuters) - Biogen Inc ( BIIB ): * BIOGEN TO ACQUIRE ALCYONE THERAPEUTICS, EXPANDING DRUG DELIVERY SOLUTION PORTFOLIO FOR KEY PRODUCT AND PIPELINE CANDIDATES * BIOGEN INC ( BIIB ) - TO BUY ALCYONE FOR $85M UPFRONT PLUS MILESTONES * BIOGEN INC ( BIIB ) - PLANS SPINRAZA DELIVERY SYSTEM LAUNCH IN 2028 Source text: Further company coverage:...
DuPont de Nemours Lowers Q3, Full-Year Sales Outlook to Reflect Spin-Off
DuPont de Nemours Lowers Q3, Full-Year Sales Outlook to Reflect Spin-Off
Sep 18, 2025
07:53 AM EDT, 09/18/2025 (MT Newswires) -- DuPont de Nemours ( DD ) Thursday said it expects Q3 adjusted earnings of $1.06 per share on net sales of about $2.98 billion, compared with August estimate of Q3 adjusted EPS of $1.15 on net sales of $3.32 billion. Analysts polled by FactSet expect non-GAAP EPS of $1.16 on sales of $3.31...
Copyright 2023-2026 - www.financetom.com All Rights Reserved